MedStar Georgetown Cancer Institute at MedStar St. Mary’s Hospital | 20650 | MedStar Health

MedStar Georgetown Cancer Institute at MedStar St. Mary’s Hospital

MedStar St. Mary's Hospital
25500 Point Lookout Rd.
First Fl.
Leonardtown, MD 20650

Welcome to the MedStar Georgetown Cancer Institute at MedStar St. Mary’s Hospital

MedStar Georgetown Cancer Institute delivers the highest quality of care in a welcoming, supportive environment. Our team at MedStar St. Mary’s Hospital offers outstanding care to patients treated for a wide variety of cancers as well as convenient access to the latest therapies, research, and clinical trials through a diverse group of nationally and internationally renowned specialists. No matter what type of cancer and other complex illnesses you may have, our oncology team works closely with you and your doctors to develop a treatment plan that’s right for you.

Our nationally-recognized doctors offer screening, prevention, research, diagnosis, treatment, personalized rehabilitation and survivorship programs at multiple locations, close to where you live and work. Our experts specialize in your specific type of cancer, and work together to develop a customized care plan to target your unique needs. This often leads to better outcomes, and more importantly, hope.

Our services

Customized support services

The cancer experience is life-changing for patients and their loved ones. Cancer patients need support before, during and after their treatment. Our goal is to provide compassionate and professional care to each one of our patients, to promote the healing process and to support them every step of the way. Our nurse navigators are dedicated to this mission.

Comprehensive care from experts with the latest breakthroughs

MedStar Health Cancer Services combine medical expertise, the latest therapies, and research across MedStar Health. Georgetown Lombardi Comprehensive Cancer Center—the Washington, D.C., region’s only National Cancer Institute-designated comprehensive cancer center—serves as our research engine. This partnership allows you access to cutting-edge clinical trials and the latest breakthroughs in cancer care.